Reglan Attorneys

Reglan (metoclopramide) is a prescription drug used to treat a number of gastrointestinal conditions including diabetic gastric stasis and gastric reflux, or heartburn. Reglan is a dopamine antagonist that increases lower esophageal sphincter pressure and improves gastrointestinal emptying.

The FDA approved Reglan, which is manufactured by Baxter Healthcare Corporation, for short-term treatment only after other methods of treatment have failed. However, evidence shows that one-third of patients are prescribed Reglan for longer than 12 weeks, which is against FDA recommendations.

Some of the more serious Reglan side effects are:

- Tardive dyskinesia - involuntary muscle movements, usually in the face and tongue, but sometimes in the trunk or extremities or Neuroleptic Malignant Syndrome (NMS)
- Parkinson's-like symptoms - slow movements, rigidity, and tremors
- Akathesia - a severe anxiety and inability to sit still
- Suicidal Tendencies and other mental depressions
- Seizures and convulsions

Some of these side effects progressively worsen and may eventually become irreversible. The label on Reglan does advise of these side effects but states that the incidence is rare. However, studies have shown that the use of Reglan can cause Tardive dyskinesia in as many as 27% of its long-term users.

If you or someone you love has suffered serious harm as a result of taking Reglan, you may be eligible to seek compensation, including medical bills, lost earning capacity, pain and suffering, and more. Contact our service today to get in touch with caring and experienced Reglan attorneys who can evaluate your case, answer your questions, and help you maximize your legal rights.

 
Select a State.

Make Contact.
After choosing a state, submit your case and we will send it to all the participating attorneys in your area.

Make the Decision.
Based on the responses you receive, choose the attorney you are most comfortable with. Response times may vary.

 
All Rights Reserved: AAFY.com
Design by: Calliope Media 2007